Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/1994
12/14/1994EP0628556A1 Imidazopyridines
12/14/1994EP0628040A1 Indole derivatives as steroid 5 alpha-reductase inhibitors
12/14/1994EP0498830B1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation
12/14/1994EP0471030B1 Glycoprotein hormone receptor molecules
12/13/1994US5373089 Oxytocin antagonist
12/08/1994WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994WO1994027990A1 INDOLE DERIVATIVES AS STEROID 5α-REDUCTASE INHIBITORS
12/08/1994CA2163350A1 Opioid receptors: compositions and methods
12/08/1994CA2125077A1 Imidazopyridine
11/1994
11/30/1994EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994CN1095720A Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
11/30/1994CN1095619A Health-care tortoise and soft-shelled turtle capsule and its prepn. method
11/24/1994WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994WO1994026767A1 Improved antiandrogens
11/24/1994WO1994026719A1 Mercapto-amide derivatives useful as neutral endopeptidase and ace inhibitors
11/24/1994WO1994026707A1 Vitamin d amide derivatives
11/24/1994WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone
11/24/1994CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994CA2162272A1 Vitamin d amide derivatives
11/24/1994CA2136303A1 Improved antiandrogens
11/23/1994EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan
11/17/1994EP0540676B1 Peptide compounds having growth hormone releasing activity
11/10/1994WO1994025485A1 Oxytocin antagonist
11/10/1994WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/09/1994EP0623140A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids
11/09/1994EP0477217B1 Stabilized, potent grf analogs
11/01/1994CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/27/1994WO1994024149A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
10/26/1994EP0620823A1 6,7$g(a)-DIFLUOROMETHYLENANDROSTA-1,4-DIEN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
10/26/1994CN1094052A Heterocycle-containing carbonic acid derivatives
10/26/1994CN1026324C 11beta-(4-isopropenylbenzene)-4,9-estrobiene, preparation of same and pharmaceutical containing same
10/25/1994US5359071 15-substituted 4-azasteroids
10/25/1994US5359030 Coupling of a peptide and polymer; therapy, diagnosis
10/13/1994WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994WO1994022481A1 Active-substance patch for releasing estradiol to the skin
10/13/1994WO1994022426A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994CA2159209A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994CA2156746A1 Active-substance patch for releasing estradiol to the skin
10/12/1994EP0619304A1 22-oxacholecalciferol derivative and production thereof
10/12/1994EP0618806A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
10/11/1994CA1332353C Pharmaceutical composition for the treatment of skin wounds
10/05/1994CN1093085A Amine derivatives
09/1994
09/29/1994WO1994021235A1 Enhanced circulation effector composition and method
09/29/1994WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/28/1994CN1092767A Spiro piperdines and homologs promote release of growth hormone
09/21/1994EP0615448A1 Sex steroid activity inhibitors
09/21/1994CN1092428A Conception promoting 19, 11beta-overbrige 4-estratrene
09/20/1994US5348967 Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A2 inhibitor containing them
09/15/1994WO1994020104A1 15-substituted 4-azasteroids
09/15/1994CA2157363A1 15-substituted 4-azasteroids
09/14/1994EP0614975A1 Glycoprotein hormone receptor molecules
09/14/1994EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
09/07/1994EP0613373A1 Risedronate delayed-release compositions
09/06/1994US5344827 Anticarcinogenic agents
09/06/1994US5344826 Tricycle steroid analogs
09/01/1994WO1994018983A1 Hormone replacement therapy
09/01/1994WO1994018982A1 Method of preventing or inhibiting fertilization
09/01/1994WO1994015587A3 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
08/1994
08/30/1994US5342850 Therapeutical agent for diabetes without adverse effect; aldose reductase inhibitor
08/23/1994US5340920 Physiologically active porcine peptide (CNP-53)
08/23/1994US5340810 Benzanilide derivatives
08/18/1994WO1994018169A1 Benzo-fused lactams promote release of growth hormone
08/18/1994CA2154687A1 Benzo-fused lactams promote release of growth hormone
08/17/1994EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
08/16/1994US5338830 Cyclic peptides having diuretic and vasodilation activity
08/16/1994CA1331457C Aromatic steroid 5-–-reductase inhibitors
08/10/1994EP0609963A1 Use of benzimidazoles and benzotriazoles in the treatment of epithelial disorders
08/09/1994US5336759 Biologically active peptide derived from frog (frog CNP)
08/09/1994US5336686 17 Methylene lactones of steroids
08/09/1994US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae
08/04/1994WO1994016709A2 Therapeutic uses and delivery systems of dehydroepiandrosterone
08/02/1994US5334706 Administration of low dose hemoglobin to increase perfusion
07/1994
07/27/1994EP0607400A1 Fluorinated 17-beta substituted-4-aza-5-alpha- andostran-3one derivatives.
07/21/1994WO1994015935A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
07/21/1994WO1994015587A2 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
07/21/1994CA2150574A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
07/13/1994EP0605484A1 Peptides having growth hormone releasing activity
07/13/1994EP0559751A4 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth)
07/12/1994US5328909 Cyclopropenone derivatives
07/07/1994WO1994014777A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
07/07/1994CA2129846A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
06/1994
06/28/1994US5324522 Hormone replacement therapy; miture of 3,5,3'-triiodothyronine and thyroxine
06/28/1994CA1330420C Compositions containing growth hormone peptide fragments
06/23/1994WO1994013648A1 1,4-benzodiazepine derivatives and their use as cck-modulators
06/23/1994WO1994013313A1 6-position modified decapeptide lhrh antagonists
06/23/1994CA2150461A1 1,4-benzodiazepine derivatives and their use as cck-modulators
06/23/1994CA2136078A1 6-position modified decapeptide lhrh antagonists
06/16/1994DE4235220A1 Gestagen wirksame 19,11ß-überbrückte 4-Estrene Progestin effective 19,11ß-bridged 4-Estrenes
06/12/1994CA2110672A1 Spiro peperidines and holologs which promote release of growth hormone
06/09/1994WO1994012880A2 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
06/09/1994CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
06/08/1994EP0600028A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
05/1994
05/31/1994US5317017 N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
05/26/1994WO1994011386A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
05/26/1994WO1994011004A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
05/26/1994CA2149427A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
05/25/1994CN1024667C Process for preparing substituted aminomethytetralins and their heterocyclic analogues
05/24/1994CA1329770C 17-methylene- and 17-ethylidene-estratrienes
05/17/1994US5312936 Angiotensin II antagonists